LitAlert ~~ GeneLit.com

    • A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31.
    • Barnekow E, Hasslow J, Liu W, Bryant P, Thutkawkorapin J, Wendt C, Czene K, Hall P, Margolin S, Lindblom A.
    • Int J Mol Sci. 2023 Feb 24;24(5):4468. doi: 10.3390/ijms24054468.
    • Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.
    • Hurwitz LM, Webb PM, Jordan SJ, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Schildkraut JM, Berchuck A, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, Wu AH, Pearce CL, Wentzensen N, Tworoger SS, Pharoah PDP, Trabert B.
    • JAMA Netw Open. 2023 Feb 1 [Feb 24];6(2):e230666. doi: 10.1001/jamanetworkopen.2023.0666.
    • Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art.
    • Boussios S, Sheriff M.
    • Int J Mol Sci. 2023 Feb 21;24(5):4301. doi: 10.3390/ijms24054301.
    • Combination Regimens May Expand PARP Inhibitor Efficacy in mCRPC.
    • Wahner A, Zhang T.
    • OncLive. 2023 Feb 21.
    • Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis.
    • Sun W, Wu Y, Ma F, Fan J, Qiao Y.
    • J Clin Med. 2023 Feb 17;12(4):1588. doi: 10.3390/jcm12041588.
    • The impact of coding germline variants on contralateral breast cancer risk and survival.
    • Morra A, Mavaddat N, Muranen TA, Ahearn TU, Allen J, Andrulis IL, Auvinen P, Becher H, Behrens S, Blomqvist C, Bojesen SE, Bolla MK, Brauch H, Camp NJ, Carvalho S, Castelao JE, Cessna MH, Chang-Claude J, Chenevix-Trench G; NBCS Collaborators; Czene K, Decker B, Dennis J, Dörk T, Dorling L, Dunning AM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa JD, Flyger H, Gago-Dominguez M, García-Closas M, Geurts-Giele WRR, Giles GG, Guénel P, Gündert M, Hahnen E, Hall P, Hamann U, Harrington PA, He W, Heikkilä P, Hooning MJ, Hoppe R, Howell A, Humphreys K; kConFab Investigators; Jakubowska A, Jung AY, Keeman R, Kristensen VN, Lubinski J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Mavroudis D, Milne RL, Mulligan AM, Newman WG, Park-Simon TW, Peterlongo P, Pharoah PDP, Rhenius V, Saloustros E, Sawyer EJ, Schmutzler RK, Shah M, Spurdle AB, Tomlinson I, Truong T, van Veen EM, Vreeswijk MPG, Wang Q, Wendt C, Yang XR, Nevanlinna H, Devilee P, Easton DF, Schmidt MK.
    • Am J Hum Genet. 2023 Feb 16:S0002-9297(23)00047-2. doi: 10.1016/j.ajhg.2023.02.003. Epub ahead of print.

    •• Research news: Coding Variants in Five Breast Cancer Risk Genes Linked to Contralateral Breast Cancer. (GenomeWeb)

    • Chinese American and Non-Hispanic White Breast Cancer Patients' Knowledge and Use of BRCA Testing.
    • Wang H, Chen LS, Hsiao HY, Hsiao SC, Han T, Chang E, Assoumou B, Wang JH.
    • Int J Environ Res Public Health. 2023 Feb 15;20(4):3384. doi: 10.3390/ijerph20043384.
    • Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review.
    • Bertozzi S, Londero AP, Xholli A, Azioni G, Di Vora R, Paudice M, Bucimazza I, Cedolini C, Cagnacci A.
    • J Clin Med. 2023 Feb 10;12(4):1422. doi: 10.3390/jcm12041422.
    • Hereditary Women's Cancer: Management and Risk-Reducing Surgery.
    • Conte C, Pelligra S, Sarpietro G, Montana GD, Della Corte L, Bifulco G, Martinelli C, Ercoli A, Palumbo M, Cianci S.
    • Medicina (Kaunas). 2023 Feb 6;59(2):300. doi: 10.3390/medicina59020300.